$AMED
AMEDISYS INC

2013 Q2 Form 10-Q Financial Statement

#000119312513311985 Filed on July 31, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2012 Q2
Revenue $316.0M $370.3M
YoY Change -14.66% 0.52%
Cost Of Revenue $176.1M $202.6M
YoY Change -13.09% 6.95%
Gross Profit $138.2M $163.4M
YoY Change -15.42% -8.72%
Gross Profit Margin 43.73% 44.13%
Selling, General & Admin $122.3M $137.3M
YoY Change -10.92% 6.11%
% of Gross Profit 88.49% 84.03%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $9.600M $9.900M
YoY Change -3.03% 2.06%
% of Gross Profit 6.95% 6.06%
Operating Expenses $131.6M $147.0M
YoY Change -10.48% 5.76%
Operating Profit $3.793M $15.36M
YoY Change -75.3% -61.67%
Interest Expense $730.0K $2.002M
YoY Change -63.54% -11.18%
% of Operating Profit 19.25% 13.04%
Other Income/Expense, Net $111.0K -$1.704M
YoY Change -106.51% -17.88%
Pretax Income $3.300M $13.65M
YoY Change -75.83% -64.06%
Income Tax $1.300M $5.666M
% Of Pretax Income 39.39% 41.5%
Net Earnings $1.800M $7.900M
YoY Change -77.22% -63.43%
Net Earnings / Revenue 0.57% 2.13%
Basic Earnings Per Share $0.06 $0.26
Diluted Earnings Per Share $0.06 $0.26
COMMON SHARES
Basic Shares Outstanding 31.16M shares 29.78M shares
Diluted Shares Outstanding 31.49M shares 30.03M shares

Balance Sheet

Concept 2013 Q2 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $30.10M $37.20M
YoY Change -19.09% 32.38%
Cash & Equivalents $30.12M $37.16M
Short-Term Investments
Other Short-Term Assets $27.00M $24.80M
YoY Change 8.87% 5.99%
Inventory
Prepaid Expenses $11.18M
Receivables $124.8M $163.2M
Other Receivables $0.00 $0.00
Total Short-Term Assets $181.8M $236.3M
YoY Change -23.06% 15.38%
LONG-TERM ASSETS
Property, Plant & Equipment $156.9M $146.2M
YoY Change 7.31% 1.25%
Goodwill $343.4M
YoY Change
Intangibles $49.34M
YoY Change
Long-Term Investments
YoY Change
Other Assets $109.2M $23.61M
YoY Change 362.59% -14.16%
Total Long-Term Assets $518.5M $622.0M
YoY Change -16.64% -45.24%
TOTAL ASSETS
Total Short-Term Assets $181.8M $236.3M
Total Long-Term Assets $518.5M $622.0M
Total Assets $700.3M $858.3M
YoY Change -18.41% -35.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $21.70M $24.43M
YoY Change -11.16% 12.04%
Accrued Expenses $130.4M $62.22M
YoY Change 109.59% -57.99%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $35.80M $60.70M
YoY Change -41.02% 71.47%
Total Short-Term Liabilities $191.0M $245.0M
YoY Change -22.04% 13.53%
LONG-TERM LIABILITIES
Long-Term Debt $39.00M $67.70M
YoY Change -42.39% -47.07%
Other Long-Term Liabilities $5.200M $4.274M
YoY Change 21.67% -22.29%
Total Long-Term Liabilities $39.00M $71.97M
YoY Change -45.81% -46.05%
TOTAL LIABILITIES
Total Short-Term Liabilities $191.0M $245.0M
Total Long-Term Liabilities $39.00M $71.97M
Total Liabilities $236.7M $317.0M
YoY Change -25.33% -23.14%
SHAREHOLDERS EQUITY
Retained Earnings $115.5M
YoY Change
Common Stock $441.5M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $17.01M
YoY Change
Treasury Stock Shares 781.4K shares
Shareholders Equity $463.6M $540.0M
YoY Change
Total Liabilities & Shareholders Equity $700.3M $858.3M
YoY Change -18.41% -35.98%

Cashflow Statement

Concept 2013 Q2 2012 Q2
OPERATING ACTIVITIES
Net Income $1.800M $7.900M
YoY Change -77.22% -63.43%
Depreciation, Depletion And Amortization $9.600M $9.900M
YoY Change -3.03% 2.06%
Cash From Operating Activities $33.60M $21.20M
YoY Change 58.49% -11.3%
INVESTING ACTIVITIES
Capital Expenditures -$9.500M -$10.00M
YoY Change -5.0% 6.38%
Acquisitions
YoY Change
Other Investing Activities $2.200M -$7.900M
YoY Change -127.85% -93.74%
Cash From Investing Activities -$7.400M -$17.80M
YoY Change -58.43% -86.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -3.100M -7.400M
YoY Change -58.11% -18.68%
NET CHANGE
Cash From Operating Activities 33.60M 21.20M
Cash From Investing Activities -7.400M -17.80M
Cash From Financing Activities -3.100M -7.400M
Net Change In Cash 23.10M -4.000M
YoY Change -677.5% -96.69%
FREE CASH FLOW
Cash From Operating Activities $33.60M $21.20M
Capital Expenditures -$9.500M -$10.00M
Free Cash Flow $43.10M $31.20M
YoY Change 38.14% -6.31%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.45
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
4962000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
590000
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
537000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-578000
us-gaap Pension Expense
PensionExpense
4363000
us-gaap Pension Expense
PensionExpense
5040000
us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
167000
us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
0
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
0
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
2082000
amed Intangible Assets Written Off
IntangibleAssetsWrittenOff
2286400
amed Intangible Assets Written Off
IntangibleAssetsWrittenOff
0
amed Cash Distribution To Noncontrolling Interest
CashDistributionToNoncontrollingInterest
93000
amed Cash Distribution To Noncontrolling Interest
CashDistributionToNoncontrollingInterest
105000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
3980000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.44
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
7882000
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
639201000
CY2012Q4 us-gaap Assets Held For Sale At Carrying Value
AssetsHeldForSaleAtCarryingValue
0
CY2013Q2 us-gaap Assets Held For Sale At Carrying Value
AssetsHeldForSaleAtCarryingValue
1550000
us-gaap Cost Of Services
CostOfServices
360233000
amed Provision For Doubtful Accounts For Continuing Operations
ProvisionForDoubtfulAccountsForContinuingOperations
8502000
amed Depreciation And Amortization For Continuing Operations
DepreciationAndAmortizationForContinuingOperations
21621000
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2013Q2 us-gaap Costs And Expenses
CostsAndExpenses
309355000
us-gaap Costs And Expenses
CostsAndExpenses
630418000
us-gaap Operating Income Loss
OperatingIncomeLoss
8783000
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
22000
us-gaap Interest Expense
InterestExpense
1836000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
700000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
196000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-561000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
8222000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3260000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-982000
us-gaap Profit Loss
ProfitLoss
3980000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-539000
us-gaap Net Income Loss
NetIncomeLoss
4519000
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31160000 shares
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29780000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30900000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29584000 shares
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31489000 shares
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30026000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31298000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29903000 shares
CY2013Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.07
CY2012Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.26
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.17
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.49
CY2013Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.01
CY2012Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.03
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.05
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2013Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.07
CY2012Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.26
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.18
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.50
CY2013Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
CY2012Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.03
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
1841000
CY2013Q2 amed Depreciation And Amortization For Continuing Operations
DepreciationAndAmortizationForContinuingOperations
11674000
CY2013Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
41121000
CY2013Q2 amed Provision For Doubtful Accounts For Continuing Operations
ProvisionForDoubtfulAccountsForContinuingOperations
4658000
CY2013Q2 us-gaap Profit Loss
ProfitLoss
1848000
CY2013Q2 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
11000
CY2013Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1224000
CY2013Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-490000
CY2013Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
74601000
CY2013Q2 amed General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
116900000
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
3793000
CY2013Q2 us-gaap Cost Of Services
CostOfServices
176077000
CY2013Q2 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
313148000
CY2013Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
337000
CY2013Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
111000
CY2013Q2 us-gaap Interest Expense
InterestExpense
730000
CY2012Q2 us-gaap Costs And Expenses
CostsAndExpenses
347711000
CY2012Q2 us-gaap Cost Of Services
CostOfServices
202586000
CY2012Q2 us-gaap Share Based Compensation
ShareBasedCompensation
2298000
CY2012Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
84000
CY2012Q2 amed Depreciation And Amortization For Continuing Operations
DepreciationAndAmortizationForContinuingOperations
9678000
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
13653000
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5666000
CY2012Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
396000
CY2012Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-126000
CY2012Q2 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
363068000
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
15357000
CY2012Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
45632000
CY2012Q2 us-gaap Interest Expense
InterestExpense
2002000
CY2012Q2 amed Provision For Doubtful Accounts For Continuing Operations
ProvisionForDoubtfulAccountsForContinuingOperations
4534000
CY2012Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1704000
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
42000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
166270000
us-gaap Share Based Compensation
ShareBasedCompensation
4780000
amed Provision For Doubtful Accounts For Continuing Operations
ProvisionForDoubtfulAccountsForContinuingOperations
10217000
us-gaap Net Income Loss
NetIncomeLoss
13302000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
127000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10530000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-1414000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3024000
us-gaap Costs And Expenses
CostsAndExpenses
690659000
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
88240000
us-gaap Profit Loss
ProfitLoss
13429000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
309000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
701000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
25373000
us-gaap Operating Income Loss
OperatingIncomeLoss
28397000
us-gaap Interest Expense
InterestExpense
4076000
us-gaap Cost Of Services
CostOfServices
401637000
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
719056000
amed Depreciation And Amortization For Continuing Operations
DepreciationAndAmortizationForContinuingOperations
19515000
CY2012Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
7903000
CY2013Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-490000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
5501000
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-1414000
CY2013Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
2338000
CY2012Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
7987000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
14843000
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
357000
CY2013Q2 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
357000
CY2012Q2 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
0
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
0
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
20071000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4519000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
32105000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2878000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
800000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-7963000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-4293000
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
100000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
19595000
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
74000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
627000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-24215000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1695000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
27904000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-26189000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
15573000
us-gaap Interest Paid
InterestPaid
2006000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
48004000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
10621000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
8722300
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
3135000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
545000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1470000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1457000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3976000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20241000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
126000
CY2013Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1848000
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1841000
CY2013Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0
CY2012Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0
CY2012Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
7966000
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
7882000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13304000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-708300
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2958600
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
370000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
400000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-35684000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27931000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
788000
us-gaap Interest Paid
InterestPaid
3494000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
5557000
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
127000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-848000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
145000
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
239000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-411000
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37158000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15020000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
8392000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1978000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
17038000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-10846000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
625000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
25722000
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
6227000
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
25500000
CY2013Q2 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
0.84 pure
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19679100
us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
0
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
25500000
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0
us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
0.83 pure
CY2013Q2 amed Maximum Percent Ownership For Equity Method Percent
MaximumPercentOwnershipForEquityMethodPercent
0.5 pure
CY2013Q2 us-gaap Cost Method Investments
CostMethodInvestments
5000000
CY2013Q2 amed Minimum Percent Ownership For Controlling Interest Percent
MinimumPercentOwnershipForControllingInterestPercent
0.5 pure
CY2012Q4 us-gaap Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
4800000
CY2012 amed Number Of Care Centers Closed
NumberOfCareCentersClosed
3 Agencies
CY2012Q2 amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
2100000
us-gaap Use Of Estimates
UseOfEstimates
<p style='margin-top:13.5pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Use of Estimates </font></p><p style='margin-top:4.5pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Our accounting and reporting policies conform with U.S.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">G</font><font style="font-family:Times New Roman;font-size:10pt;">AAP. In preparing the </font><font style="font-family:Times New Roman;font-size:10pt;">unaudited condensed </font><font style="font-family:Times New Roman;font-size:10pt;">consolidated financial statements, we are required to make estimates and assumptions that impact the amounts reported in the</font><font style="font-family:Times New Roman;font-size:10pt;"> condensed</font><font style="font-family:Times New Roman;font-size:10pt;"> consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates. </font></p>
us-gaap Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
<p style='margin-top:13.5pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;margin-left:0px;">Reclassifications and Comparability</font><font style="font-family:Times New Roman;font-size:10pt;font-weight:bold;font-style:italic;"> </font></p><p style='margin-top:13.5pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Certain reclassifications have been made to prior period's financial statements in order to conform to the current period's presentation</font><font style="font-family:Times New Roman;font-size:10pt;">. </font><font style="font-family:Times New Roman;font-size:10pt;">W</font><font style="font-family:Times New Roman;font-size:10pt;">e exited three home health care centers</font><font style="font-family:Times New Roman;font-size:10pt;"> during 2012, and have </font><font style="font-family:Times New Roman;font-size:10pt;">committed to a plan to divest approximately 3</font><font style="font-family:Times New Roman;font-size:10pt;">4</font><font style="font-family:Times New Roman;font-size:10pt;"> care centers. In accordance with applicable accounting guidance</font><font style="font-family:Times New Roman;font-size:10pt;">,</font><font style="font-family:Times New Roman;font-size:10pt;"> the results of operations for these care centers are presented in discontinued operations in our condensed consolidated financial statements. See Note </font><font style="font-family:Times New Roman;font-size:10pt;">3</font><font style="font-family:Times New Roman;font-size:10pt;"> for additional information regarding our discontinued operations.</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">In addition</font><font style="font-family:Times New Roman;font-size:10pt;"> during 2013</font><font style="font-family:Times New Roman;font-size:10pt;">, w</font><font style="font-family:Times New Roman;font-size:10pt;">e have consolidated </font><font style="font-family:Times New Roman;font-size:10pt;">2</font><font style="font-family:Times New Roman;font-size:10pt;">8</font><font style="font-family:Times New Roman;font-size:10pt;"> care centers with care centers servicing the same market</font><font style="font-family:Times New Roman;font-size:10pt;">s,</font><font style="font-family:Times New Roman;font-size:10pt;"> </font><font style="font-family:Times New Roman;font-size:10pt;">which may affect the comparability of our operating results.</font></p><p style='margin-top:13.5pt; margin-bottom:0pt'>&#160;</p>
CY2013Q2 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
37 States
CY2013Q2 amed Number Of Care Centers Available For Sale
NumberOfCareCentersAvailableForSale
34 Agencies
amed Number Of Care Centers Consolidated
NumberOfCareCentersConsolidated
28 Agencies
amed Percentage Of Total Reimbursement Of Outlier Payment
PercentageOfTotalReimbursementOfOutlierPayment
0.1 pure
amed Episodes Of Progress That Begin During Reporting Period
EpisodesOfProgressThatBeginDuringReportingPeriod
60
CY2013Q2 amed Estimated Amount Due Back To Medicare In Other Accrued Liabilities
EstimatedAmountDueBackToMedicareInOtherAccruedLiabilities
4000000
CY2012Q4 amed Estimated Amount Due Back To Medicare In Other Accrued Liabilities
EstimatedAmountDueBackToMedicareInOtherAccruedLiabilities
4800000
amed Episode Of Care As Episodic Based Revenue
EpisodeOfCareAsEpisodicBasedRevenue
60
amed Historical Collection Rate From Medicare
HistoricalCollectionRateFromMedicare
0.99 pure
amed First Threshold Of Therapy Services Required
FirstThresholdOfTherapyServicesRequired
6 Number_of_Visits
amed Low Utilization Payment Adjustment Number Of Visits
LowUtilizationPaymentAdjustmentNumberOfVisits
5 Number_of_Visits
amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.99 pure
amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.98 pure
amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
6600000
amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
4700000
amed Second Threshold Of Services Required
SecondThresholdOfServicesRequired
14 Number_of_Visits
amed Third Threshold Of Therapy Services Required
ThirdThresholdOfTherapyServicesRequired
20 Number_of_Visits
amed Portion Of Patient Accounts Receivable Derived From Medicare
PortionOfPatientAccountsReceivableDerivedFromMedicare
0.71 pure
CY2012 amed Portion Of Patient Accounts Receivable Derived From Medicare
PortionOfPatientAccountsReceivableDerivedFromMedicare
0.68 pure
CY2013Q2 amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.99 pure
CY2012Q2 amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.97 pure
CY2013Q2 amed Revenue Adjustment To Medicare Revenue
RevenueAdjustmentToMedicareRevenue
2800000
amed Minimum Days Accounts Receivable Outstanding Fully Reserved
MinimumDaysAccountsReceivableOutstandingFullyReserved
365
amed Rate Of Request For Anticipated Payment Submitted For Initial Episode Of Care
RateOfRequestForAnticipatedPaymentSubmittedForInitialEpisodeOfCare
0.6 pure
amed Rate Of Request For Anticipated Payment Submitted For Subsequent Episodes Of Care
RateOfRequestForAnticipatedPaymentSubmittedForSubsequentEpisodesOfCare
0.5 pure
amed Maximum Days To Submit Final Bill From Start Of Episode
MaximumDaysToSubmitFinalBillFromStartOfEpisode
120
amed Percentage Of Patient Receivables Outstanding
PercentageOfPatientReceivablesOutstanding
0.1 pure
amed Maximum Days To Submit Final Bill From Date Request For Anticipated Payment Was Paid
MaximumDaysToSubmitFinalBillFromDateRequestForAnticipatedPaymentWasPaid
60
CY2013Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
74800000
CY2012Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
531000 shares
CY2012Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
23000 shares
amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
303000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
595000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
16000 shares
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-1000000
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
30400000
CY2013Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-800000
CY2013Q2 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
-300000
CY2013Q2 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
11700000
CY2012Q2 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
15300000
CY2012Q2 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
0
CY2012Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
0
CY2013Q2 amed Number Of Care Centers Consolidated
NumberOfCareCentersConsolidated
19 Agencies
CY2013Q2 amed Number Of Care Centers Included In Divestiture Plan
NumberOfCareCentersIncludedInDivestiturePlan
50 Agencies
CY2013Q2 amed Number Of Care Centers Sold
NumberOfCareCentersSold
3 Agencies
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-1600000
CY2013Q2 us-gaap Long Term Debt
LongTermDebt
74800000
CY2013Q2 amed Fixed Charge Coverage Ratio
FixedChargeCoverageRatio
1.27 pure
CY2013Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
39000000
CY2012Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
66900000
CY2013Q2 amed Line Of Credit Facility Debt Restrictions
LineOfCreditFacilityDebtRestrictions
2.0 pure
CY2013Q2 amed Maximum Leverage Ratio
MaximumLeverageRatio
2.0 pure
CY2013Q2 amed Minimum Fixed Charge Coverage Ratio
MinimumFixedChargeCoverageRatio
1.25 pure
CY2013Q2 amed Total Leverage Ratio
TotalLeverageRatio
1.01 pure
amed Health Insurance Retention Limit
HealthInsuranceRetentionLimit
900000
amed Professional Liability Insurance Retention Limit
ProfessionalLiabilityInsuranceRetentionLimit
300000
amed Workers Compensation Insurance Retention Limit
WorkersCompensationInsuranceRetentionLimit
500000
amed Medicare Revenue
MedicareRevenue
4000000
amed General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
240100000
CY2012Q2 amed General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
130900000
amed General And Administrative Expense Segment
GeneralAndAdministrativeExpenseSegment
259300000

Files In Submission

Name View Source Status
0001193125-13-311985-index-headers.html Edgar Link pending
0001193125-13-311985-index.html Edgar Link pending
0001193125-13-311985.txt Edgar Link pending
0001193125-13-311985-xbrl.zip Edgar Link pending
amed-20130630.xml Edgar Link completed
amed-20130630.xsd Edgar Link pending
amed-20130630_cal.xml Edgar Link unprocessable
amed-20130630_def.xml Edgar Link unprocessable
amed-20130630_lab.xml Edgar Link unprocessable
amed-20130630_pre.xml Edgar Link unprocessable
d555683d10q.htm Edgar Link pending
d555683dex311.htm Edgar Link pending
d555683dex312.htm Edgar Link pending
d555683dex321.htm Edgar Link pending
d555683dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
g555683g02q19.jpg Edgar Link pending
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R31.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending